Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved a generic irbesartan product from Camber Pharmaceuticals through an original ANDA. The product is indicated for hypertension an…
-
FDA approval · 2012-09-27FDA Approved: IRBESARTAN — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's Original Application for IRBESARTAN, authorizing the marketing of the generic irbesartan. The approv…
-
FDA approval · 2012-09-26FDA Approved: TORSEMIDE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for torsemide from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Melatonin Supplements for Improving Sleep in Individuals With Hypertension [Phase 2]
Phase 2 clinical trial evaluating melatonin supplements to improve sleep in people with hypertension. The study is completed and results wer…
-
CLINICAL_TRIALS trial_result · 2012-09-25Clinical Trial Update: Identification of the Region of Vitamin D Responsiveness
This completed clinical trial update reports on identifying the region of vitamin D responsiveness in people with diabetes mellitus and hype…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-09-24FDA Approved: LOSARTAN POTASSIUM — Original Application (Micro Labs Limited)
FDA approved Losartan potassium under an Original Application for Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
This clinical trial update reports the completion of a Boehringer Ingelheim study evaluating telmisartan for blood pressure control in high-…
-
FDA approval · 2012-09-24FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (Accord Healthcare Inc.)
FDA approved Accord Healthcare's original application for generic hydrochlorothiazide. The drug is indicated for hypertension and edema.
-
FDA approval · 2012-09-21FDA Approved: LOTENSIN — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for Lotensin (benazepril hydrochloride) submitted by Validus Pharmaceuticals LLC.
-
FDA approval · 2012-09-21FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Padagis US LLC)
FDA supplemental approval for Benazepril hydrochloride and hydrochlorothiazide (Padagis US LLC) to update labeling related to the product.
-
FDA approval · 2012-09-21FDA Approved: VALSARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved the Original Application for a generic fixed-dose combination of valsartan and hydrochlorothiazide, manufactured by Mylan. The …
-
EMA withdrawal · 2012-09-20EMA Withdrawn: Rasitrio (aliskiren;amlodipine;hydrochlorothiazide) — Novartis Europharm Ltd.
EMA has withdrawn Rasitrio (aliskiren; amlodipine; hydrochlorothiazide) from the market for hypertension.
-
FDA approval · 2012-09-20FDA Approved: MICARDIS — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)
FDA approved a supplemental application for Micardis (telmisartan) submitted by Boehringer Ingelheim Pharmaceuticals, Inc.
-
EMA withdrawal · 2012-09-20EMA Withdrawn: Riprazo HCT (aliskiren;hydrochlorothiazide) — Novartis Europharm Ltd.
EMA withdrew Riprazo HCT (aliskiren and hydrochlorothiazide) from the market.
-
CLINICAL_TRIALS trial_result · 2012-09-20Clinical Trial Update: An Eight-week Randomized,Double-blind Study to Evaluate the Efficacy and Safety of Fixed-dose Combinations of T80+A5 Versus A5 Monotherapy in Patients With Hypertension Who Fail to Respond Adequately to Treatment With A5 Monotherapy [Phase 3]
This Phase 3 randomized, double-blind study compared fixed-dose combinations of T80 plus A5 to A5 monotherapy in hypertension patients who d…
-
CLINICAL_TRIALS research · 2012-09-20Clinical Trial Update: Improving Antihypertensive and Lipid-Lowering Therapy [NA]
This clinical trial update concerns improving antihypertensive and lipid-lowering therapy. No phase or status details are provided.
-
CLINICAL_TRIALS research · 2012-09-19Clinical Trial Update: Potassium Intake in Patients With Chronic Kidney Disease [NA]
A completed clinical trial conducted by Johns Hopkins University on potassium intake in patients with chronic kidney disease and hypertensio…
-
FDA approval · 2012-09-18FDA Approved: BENICAR HCT — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Benicar HCT (olmesartan medoxomil-hydrochlorothiazide) from Cosette Pharmaceuticals, Inc. Th…
-
FDA approval · 2012-09-18FDA Approved: TORSEMIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for torsemide from Rising Pharma Holdings, Inc., indicating regulatory approval of changes to the to…
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
FDA approved the original generic product Losartan Potassium and Hydrochlorothiazide from Jubilant Cadista Pharmaceuticals Inc. for hyperten…
-
FDA approval · 2012-09-18FDA Approved: LOSARTAN POTASSIUM TABLETS, 25 MG — Original Application (Jubilant Cadista Pharmaceuticals Inc.)
The FDA approves Jubilant Cadista's Losartan Potassium tablets 25 mg as an original ANDA, providing a generic version of losartan for hypert…
-
CLINICAL_TRIALS research · 2012-09-14Clinical Trial Update: Ambulatory Versus Home Blood Pressure Monitoring in Obstructive Sleep Apnea
A clinical trial update comparing ambulatory versus home blood pressure monitoring in people with obstructive sleep apnea and hypertension; …
-
FDA approval · 2012-09-13FDA Approved: VASERETIC — Supplemental Application (Bausch Health US, LLC)
The FDA approved a supplemental application for VASERETIC (enalapril maleate and hydrochlorothiazide) submitted by Bausch Health US, LLC.
-
CLINICAL_TRIALS trial_result · 2012-09-13Clinical Trial Update: CKD-828 Telmisartan Non-Responder Trial [Phase 3]
A completed Phase 3 trial conducted by Chong Kun Dang Pharmaceutical evaluating CKD-828 in telmisartan non-responders for hypertension.
-
CLINICAL_TRIALS research · 2012-09-11Clinical Trial Update: Evaluation of Nocturnal Hypertension and Correlation With Target-Organ Damage
A clinical trial update from the University of Athens assessing nocturnal hypertension and its correlation with target-organ damage.